FoxO4-DRI and Senolytic Research

Cellular senescence is a state in which cells permanently stop dividing but do not die. Senescent cells accumulate with age and in response to stress, DNA damage, and oncogene activation. While senescence serves protective functions (tumor suppression, wound healing), the chronic accumulation of senescent cells drives a pro-inflammatory state known as the Senescence-Associated Secretory Phenotype (SASP).nnSASP involves the secretion of inflammatory cytokines, chemokines, and proteases that damage surrounding tissue and promote a chronic low-grade inflammatory state associated with many age-related conditions.

Senescent cells resist apoptosis (programmed cell death) through several survival mechanisms. Research has identified that the transcription factor FoxO4 plays a key role in maintaining senescent cell survival by interacting with p53 to suppress apoptotic signaling.nnFoxO4-DRI is a D-amino acid retro-inverso peptide u2014 a modified form of a FoxO4 sequence that is resistant to proteolytic degradation. Research suggests that FoxO4-DRI disrupts the FoxO4-p53 interaction, restoring apoptotic signaling specifically in senescent cells while leaving healthy cells largely unaffected.

Key research areas for FoxO4-DRI:nu2022 Selective senescent cell clearance in aged tissue modelsnu2022 Physical fitness and muscle function in aging modelsnu2022 Kidney function in chemotherapy-induced senescence modelsnu2022 Hair follicle regeneration in aging modelsnu2022 Liver function and metabolic health in aged animal modelsnnThe selectivity of FoxO4-DRI for senescent cells (versus healthy cells) is a key research focus, as non-selective induction of apoptosis would be harmful. Current research continues to characterize the specificity and safety profile of this compound class.nnAll BetterBio Synthesis FoxO4-DRI is supplied for Research Use Only (RUO).